HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.

AbstractBACKGROUND:
Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal disorder characterized by fibroproliferation and excessive accumulation of extracellular matrix in the lung.
METHODS AND FINDINGS:
Using oligonucleotide arrays, we identified osteopontin as one of the genes that significantly distinguishes IPF from normal lungs. Osteopontin was localized to alveolar epithelial cells in IPF lungs and was also significantly elevated in bronchoalveolar lavage from IPF patients. To study the fibrosis-relevant effects of osteopontin we stimulated primary human lung fibroblasts and alveolar epithelial cells (A549) with recombinant osteopontin. Osteopontin induced a significant increase of migration and proliferation in both fibroblasts and epithelial cells. Epithelial growth was inhibited by the pentapeptide Gly-Arg-Gly-Asp-Ser (GRGDS) and antibody to CD44, while fibroproliferation was inhibited by GRGDS and antibody to alphavbeta3 integrin. Fibroblast and epithelial cell migration were inhibited by GRGDS, anti-CD44, and anti-alphavbeta3. In fibroblasts, osteopontin up-regulated tissue inhibitor of metalloprotease-1 and type I collagen, and down-regulated matrix metalloprotease-1 (MMP-1) expression, while in A549 cells it caused up-regulation of MMP-7. In human IPF lungs, osteopontin colocalized with MMP-7 in alveolar epithelial cells, and application of weakest link statistical models to microarray data suggested a significant interaction between osteopontin and MMP-7.
CONCLUSIONS:
Our results provide a potential mechanism by which osteopontin secreted from the alveolar epithelium may exert a profibrotic effect in IPF lungs and highlight osteopontin as a potential target for therapeutic intervention in this incurable disease.
AuthorsAnnie Pardo, Kevin Gibson, José Cisneros, Thomas J Richards, Yinke Yang, Carina Becerril, Samueal Yousem, Iliana Herrera, Victor Ruiz, Moisés Selman, Naftali Kaminski
JournalPLoS medicine (PLoS Med) Vol. 2 Issue 9 Pg. e251 (Sep 2005) ISSN: 1549-1676 [Electronic] United States
PMID16128620 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Recombinant Proteins
  • SPP1 protein, human
  • Sialoglycoproteins
  • Tissue Inhibitor of Metalloproteinase-1
  • Osteopontin
  • MMP7 protein, human
  • Matrix Metalloproteinase 7
  • Matrix Metalloproteinase 1
Topics
  • Bronchoalveolar Lavage Fluid (chemistry)
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Epithelial Cells (drug effects, metabolism)
  • Extracellular Matrix (metabolism)
  • Female
  • Gene Expression Profiling
  • Humans
  • Lung (metabolism)
  • Male
  • Matrix Metalloproteinase 1 (genetics, metabolism)
  • Matrix Metalloproteinase 7 (metabolism)
  • Middle Aged
  • Molecular Sequence Data
  • Osteopontin
  • Pulmonary Fibrosis (metabolism, pathology)
  • Recombinant Proteins (pharmacology)
  • Sialoglycoproteins (metabolism, pharmacology)
  • Tissue Inhibitor of Metalloproteinase-1 (genetics, metabolism)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: